http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0474115-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47cc435e1d443f13180f7766df104d9d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 |
| filingDate | 1990-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2099a6371d8bea51197d63d4e24f22c2 |
| publicationDate | 1992-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0474115-A |
| titleOfInvention | Sustained release suppository |
| abstract | PURPOSE: To provide a sustained release suppository containing a drug-active component and curdlan, enabling the sustained release of the drug active component, eliminable by evacuation after use and exhibiting high safety. n CONSTITUTION: The objective suppository contains a drug-active component and curdlan. Preferable examples of the drug-active component are indomethacin, diclofenac sodium and ibuprofen. Curdlan is a water-insoluble straight-chain polysaccharide having a polymerization degree of about 500 and called as β -1,3-glucan. Curdlan is produced by culturing a curdland-producing soil bacterium (Alcaligenes faecalis var. mixogenes) or is easily available from the market. n COPYRIGHT: (C)1992,JPO&Japio |
| priorityDate | 1990-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.